Canada markets open in 6 hours 19 minutes

Context Therapeutics Inc. (CNTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.1800+0.0200 (+0.93%)
At close: 04:00PM EDT
2.2000 +0.02 (+0.92%)
After hours: 06:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 160.50M
Enterprise Value 135.37M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)19.01
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 1.60

Trading Information

Stock Price History

Beta (5Y Monthly) 2.32
52-Week Change 365.15%
S&P500 52-Week Change 324.43%
52 Week High 32.2400
52 Week Low 30.7700
50-Day Moving Average 31.7681
200-Day Moving Average 31.2730

Share Statistics

Avg Vol (3 month) 3713.62k
Avg Vol (10 day) 3865.31k
Shares Outstanding 575M
Implied Shares Outstanding 675M
Float 843.87M
% Held by Insiders 12.78%
% Held by Institutions 146.95%
Shares Short (May 15, 2024) 41.01M
Short Ratio (May 15, 2024) 40.75
Short % of Float (May 15, 2024) 41.36%
Short % of Shares Outstanding (May 15, 2024) 41.34%
Shares Short (prior month Apr 15, 2024) 440.41k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-64.59%
Return on Equity (ttm)-114.72%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -22.22M
Net Income Avi to Common (ttm)-21.32M
Diluted EPS (ttm)-1.3300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)10.09M
Total Cash Per Share (mrq)0.14
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.23
Book Value Per Share (mrq)0.53

Cash Flow Statement

Operating Cash Flow (ttm)-19.68M
Levered Free Cash Flow (ttm)-12.27M